Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?

BACKGROUND: Visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection remains a major problem in Ethiopia, India, and Brazil. Tuberculosis (TB), a treatable factor, could contribute to high mortality (up to 25%) in VL-HIV coinfection. However, the current evidence on the prevalence...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: van Griensven, Johan, Mohammed, Rezika, Ritmeijer, Koert, Burza, Sakib, Diro, Ermias
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Major Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5925430/
https://ncbi.nlm.nih.gov/pubmed/29732379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy059
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items